Frank Ebetino
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$2.1MFederal grants as PI4 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $2.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 3, 2023 | NIH | SBIR Phase I A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures | $297K | BIOVINC, LLC |
| Sep 1, 2017 | NIH | STTR Phase II Bone targeted antimicrobials for biofilm-mediated osteolytic infection treatment | $1.5M | BIOVINC, LLC with UNIVERSITY OF SOUTHERN CALIFORNIA |
| Jul 1, 2016 | NIH | SBIR Phase I Bone targeted delivery of an antimicrobial drug for osteomyelitis therapy | $181K | BIOVINC, LLC |
| Jan 8, 2016 | NIH | STTR Phase I Bone targeted antimicrobials for biofilm-mediated osteolytic infection treatment | $150K | BIOVINC, LLC |
Peer ranks
Federal funding#933
Awards as PI#566
Patents#273
Companies
- BIOVINC, LLCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.